Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$71.48 - $86.85 $1.82 Million - $2.21 Million
-25,400 Reduced 50.4%
25,000 $2.07 Million
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $1.52 Million - $1.89 Million
20,400 Added 68.0%
50,400 $3.89 Million
Q4 2021

Feb 15, 2022

SELL
$71.72 - $91.47 $1.61 Million - $2.06 Million
-22,500 Reduced 42.86%
30,000 $2.65 Million
Q3 2021

Nov 15, 2021

BUY
$74.77 - $85.47 $657,976 - $752,136
8,800 Added 20.14%
52,500 $4.06 Million
Q2 2021

Aug 16, 2021

SELL
$75.51 - $84.79 $98,163 - $110,227
-1,300 Reduced 2.89%
43,700 $3.65 Million
Q1 2021

May 17, 2021

SELL
$74.73 - $90.69 $10.8 Million - $13.1 Million
-144,800 Reduced 76.29%
45,000 $3.4 Million
Q4 2020

Feb 16, 2021

BUY
$72.61 - $90.2 $12.7 Million - $15.8 Million
174,800 Added 1165.33%
189,800 $16.6 Million
Q3 2020

Nov 13, 2020

BUY
$71.87 - $131.03 $1.08 Million - $1.97 Million
15,000 New
15,000 $1.14 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.